| Jan 17 2025 |
Grassley Defends Constitutionality of False Claims Act’s Qui Tam Provisions in Amicus Brief |
Kohn, Kohn & Colapinto |
| Jan 17 2025 |
Maryland’s FAMLI Program, Part I: An Overview of The Law |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 17 2025 |
Michigan’s Earned Sick Time Act – Legislative Update |
Varnum LLP |
| Jan 17 2025 |
FDA Revokes Authorization for the Use of Red Dye No. 3 in Food and Ingestible Drugs |
K&L Gates LLP |
| Jan 17 2025 |
DOJ’s False Claims Act Recoveries Top $2.9 Billion in FY 2024, but Health Care Numbers Dip—What Could FY 2025 Hold for Health Care Enforcement? |
Epstein Becker & Green, P.C. |
| Jan 17 2025 |
DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain |
McDermott Will & Schulte LLP |
| Jan 17 2025 |
McDermott+ Check-Up: January 17, 2025 |
McDermott Will & Schulte LLP |
| Jan 17 2025 |
Navigating Employer Obligations During California’s Wildfire Disasters |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 17 2025 |
2024 False Claims Act Statistics Show More Cases Filed Than Ever Before |
Bradley Arant Boult Cummings LLP |
| Jan 17 2025 |
DOJ Reports Nearly $3 Billion in FCA Settlements, Judgments for FY 2024 |
ArentFox Schiff LLP |
| Jan 17 2025 |
US Department of Justice Announces US$2.9 Billion in Fiscal Year 2024 False Claims Act Recoveries |
K&L Gates LLP |
| Jan 17 2025 |
EnforceMintz — Scienter, Causation, and Constitutional Questions: 2024’s Three Key FCA Litigation Issues |
Mintz |
| Jan 16 2025 |
Ceramtec GMBH v. Coorstek Biocermanics LLC |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 16 2025 |
New York City Publishes Updated FAQs for Earned Safe and Sick Time Act |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 16 2025 |
California Attorney General Issues Two Advisories Summarizing Law Applicable to AI |
Jackson Lewis P.C. |
| Jan 16 2025 |
Whistleblower Awarded $1.8 Million for Reporting Hospital Admissions Kickback Scheme |
Tycko & Zavareei LLP |
| Jan 16 2025 |
Tickled Pink No More |
Miller Canfield |
| Jan 16 2025 |
DEA Tightens Buprenorphine Telemedicine Prescribing Rules |
Foley & Lardner LLP |
| Jan 16 2025 |
DOL: Employers Cannot Mandate PTO Use with State/Local Paid Leave Benefits During FMLA |
Proskauer Rose LLP |
| Jan 16 2025 |
EnforceMintz — Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025 |
Mintz |
| Jan 16 2025 |
EnforceMintz — Long Tail of Pandemic Fraud Schemes Will Likely Result in Continued Enforcement for Years to Come |
Mintz |
| Jan 16 2025 |
EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them? |
Mintz |
| Jan 16 2025 |
EnforceMintz — Novel Criminal Charges and Emerging Civil Trends from Opioid Enforcement in 2024 |
Mintz |
| Jan 16 2025 |
California AG Issues AI-Related Legal Guidelines for Developers and Healthcare Entities |
Robinson & Cole LLP |
| Jan 16 2025 |
New Year, New Leave Laws – Understanding State Leave Law Updates Effective January 1, 2025 |
Bradley Arant Boult Cummings LLP |
| Jan 16 2025 |
Recent Developments in Health Care Cybersecurity and Oversight: 2024 Wrap Up and 2025 Outlook |
Epstein Becker & Green, P.C. |
| Jan 16 2025 |
DOJ Reports Substantial Procurement Fraud Recoveries in FY 2024 |
Bradley Arant Boult Cummings LLP |
| Jan 15 2025 |
Second Circuit Revives New York Reproductive Health Bias Law’s Notice Requirement for Employee Handbooks |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 15 2025 |
Congress Declines to Extend HDHP First-Dollar Telehealth Coverage Relief |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 15 2025 |
This Week in 340B: January 7 – 13, 2025 |
McDermott Will & Schulte LLP |
| Jan 15 2025 |
December 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Jan 15 2025 |
HHS-OCR’s Proposed Rule and HIPAA Security Risk Assessment |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Jan 15 2025 |
New Artificial Intelligence (AI) Regulations and Potential Fiduciary Implications |
Foley & Lardner LLP |
| Jan 15 2025 |
The Telehealth Extension Has Ended…For Now |
Foley & Lardner LLP |
| Jan 15 2025 |
FDA Announces Red No. 3 Authorizations to be Revoked as Matter of Law, not Safety |
Keller and Heckman LLP |
